This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Minitran" – news · newspapers · books · scholar · JSTOR (August 2014) |
Minitran is a commercial psychiatric drug used as a tranquilliser and antidepressant. It is manufactured in Greece by Adelco S.A. and sold in form of yellow-coloured sugar-coated tablets.
It contains Amitriptyline hydrochloride and Perphenazine.
It is sold in the following forms:
- Minitran 2-10: 2 mg Perphenazine and 10 mg Amitriptyline hydrochloride in each tablet.
- Minitran 2-25: 2 mg Perphenazine and 25 mg Amitriptyline hydrochloride in each tablet.
- Minitran 4-10: 4 mg Perphenazine and 10 mg Amitriptyline hydrochloride in each tablet.
- Minitran 4-25: 4 mg Perphenazine and 25 mg Amitriptyline hydrochloride in each tablet.
Minitran is also a pharmaceutical drug for the treatment of Angina, manufactured by 3M.
It contains glyceryl trinitrate and is sold in patch form. It is sold in the following strengths:
- Minitran 5 contains 18 mg of glyceryl trinitrate and delivers 5 mg in 24 hours
- Minitran 10: contains 36 mg of glyceryl trinitrate and delivers 10 mg in 24 hours
- Minitran 15: contains 54 mg of glyceryl trinitrate and delivers 15 mg in 24 hours
It is also marketed as Discotrine in some countries.
See also
References
- "Minitran". US GOV.